174 related articles for article (PubMed ID: 3255105)
1. Lecithin:cholesterol acyltransferase activation by synthetic amphipathic peptides.
Subbarao NK; Fielding CJ; Hamilton RL; Szoka FC
Proteins; 1988; 3(3):187-98. PubMed ID: 3255105
[TBL] [Abstract][Full Text] [Related]
2. Studies of synthetic peptides of human apolipoprotein A-I containing tandem amphipathic alpha-helixes.
Mishra VK; Palgunachari MN; Datta G; Phillips MC; Lund-Katz S; Adeyeye SO; Segrest JP; Anantharamaiah GM
Biochemistry; 1998 Jul; 37(28):10313-24. PubMed ID: 9665740
[TBL] [Abstract][Full Text] [Related]
3. Effect of end group blockage on the properties of a class A amphipathic helical peptide.
Venkatachalapathi YV; Phillips MC; Epand RM; Epand RF; Tytler EM; Segrest JP; Anantharamaiah GM
Proteins; 1993 Apr; 15(4):349-59. PubMed ID: 8460106
[TBL] [Abstract][Full Text] [Related]
4. Interaction of model class A1, class A2, and class Y amphipathic helical peptides with membranes.
Mishra VK; Palgunachari MN
Biochemistry; 1996 Aug; 35(34):11210-20. PubMed ID: 8780526
[TBL] [Abstract][Full Text] [Related]
5. GALA: a designed synthetic pH-responsive amphipathic peptide with applications in drug and gene delivery.
Li W; Nicol F; Szoka FC
Adv Drug Deliv Rev; 2004 Apr; 56(7):967-85. PubMed ID: 15066755
[TBL] [Abstract][Full Text] [Related]
6. Design of a new class of amphipathic helical peptides for the plasma apolipoproteins that promote cellular cholesterol efflux but do not activate LCAT.
Labeur C; Lins L; Vanloo B; Baert J; Brasseur R; Rosseneu M
Arterioscler Thromb Vasc Biol; 1997 Mar; 17(3):580-8. PubMed ID: 9102180
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of amphiphilic alpha-helical model peptides with systematically varied hydrophobic-hydrophilic balance and their interaction with lipid- and bio-membranes.
Kiyota T; Lee S; Sugihara G
Biochemistry; 1996 Oct; 35(40):13196-204. PubMed ID: 8855958
[TBL] [Abstract][Full Text] [Related]
8. The lipid-free structure of apolipoprotein A-I: effects of amino-terminal deletions.
Rogers DP; Roberts LM; Lebowitz J; Datta G; Anantharamaiah GM; Engler JA; Brouillette CG
Biochemistry; 1998 Aug; 37(34):11714-25. PubMed ID: 9718294
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.
Peelman F; Goethals M; Vanloo B; Labeur C; Brasseur R; Vandekerckhove J; Rosseneu M
Eur J Biochem; 1997 Nov; 249(3):708-15. PubMed ID: 9395317
[TBL] [Abstract][Full Text] [Related]
10. Conformation and lipid binding properties of four peptides derived from the membrane-binding domain of CTP:phosphocholine cytidylyltransferase.
Johnson JE; Rao NM; Hui SW; Cornell RB
Biochemistry; 1998 Jun; 37(26):9509-19. PubMed ID: 9649334
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the hydrophobicity gradient of an amphipathic peptide to its mode of association with lipids.
Pérez-Méndez O; Vanloo B; Decout A; Goethals M; Peelman F; Vandekerckhove J; Brasseur R; Rosseneu M
Eur J Biochem; 1998 Sep; 256(3):570-9. PubMed ID: 9780233
[TBL] [Abstract][Full Text] [Related]
12. Activation of lecithin:cholesterol acyltransferase by a synthetic model lipid-associating peptide.
Pownall HJ; Hu A; Gotto AM; Albers JJ; Sparrow JT
Proc Natl Acad Sci U S A; 1980 Jun; 77(6):3154-8. PubMed ID: 6774331
[TBL] [Abstract][Full Text] [Related]
13. Insertion and orientation of a synthetic peptide representing the C-terminus of the A1 domain of Shiga toxin into phospholipid membranes.
Saleh MT; Ferguson J; Boggs JM; Gariépy J
Biochemistry; 1996 Jul; 35(29):9325-34. PubMed ID: 8755710
[TBL] [Abstract][Full Text] [Related]
14. Anionic phospholipids modulate peptide insertion into membranes.
Liu LP; Deber CM
Biochemistry; 1997 May; 36(18):5476-82. PubMed ID: 9154930
[TBL] [Abstract][Full Text] [Related]
15. Stabilization of helical structure in two 17-residue amphipathic analogues of the C-terminal peptide of cytochrome C.
Collawn JF; Paterson Y
Biopolymers; 1990 Jul-Aug 5; 29(8-9):1289-96. PubMed ID: 2164428
[TBL] [Abstract][Full Text] [Related]
16. Conformation and lipid binding of the N-terminal (1-44) domain of human apolipoprotein A-I.
Zhu HL; Atkinson D
Biochemistry; 2004 Oct; 43(41):13156-64. PubMed ID: 15476409
[TBL] [Abstract][Full Text] [Related]
17. Cell selectivity and mechanism of action of antimicrobial model peptides containing peptoid residues.
Song YM; Park Y; Lim SS; Yang ST; Woo ER; Park IS; Lee JS; Kim JI; Hahm KS; Kim Y; Shin SY
Biochemistry; 2005 Sep; 44(36):12094-106. PubMed ID: 16142907
[TBL] [Abstract][Full Text] [Related]
18. Composition and structural and functional properties of discoidal and spherical phospholipid-apoE3 complexes.
De Pauw M; Vanloo B; Dergunov AD; Devreese AM; Baert J; Brasseur R; Rosseneu M
Biochemistry (Mosc); 1997 Mar; 62(3):251-63. PubMed ID: 9275298
[TBL] [Abstract][Full Text] [Related]
19. Studies of synthetic peptide analogs of the amphipathic helix. Effect of charge distribution, hydrophobicity, and secondary structure on lipid association and lecithin:cholesterol acyltransferase activation.
Epand RM; Gawish A; Iqbal M; Gupta KB; Chen CH; Segrest JP; Anantharamaiah GM
J Biol Chem; 1987 Jul; 262(19):9389-96. PubMed ID: 3597415
[TBL] [Abstract][Full Text] [Related]
20. Secondary structure and orientation of the amphipathic peptide GALA in lipid structures. An infrared-spectroscopic approach.
Goormaghtigh E; De Meutter J; Szoka F; Cabiaux V; Parente RA; Ruysschaert JM
Eur J Biochem; 1991 Jan; 195(2):421-9. PubMed ID: 1997324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
